ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · IEX Real-Time Price · USD
1.990
-0.140 (-6.57%)
At close: Jul 19, 2024, 4:00 PM
2.110
+0.120 (6.03%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

ProMIS Neurosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Cash & Equivalents
2.512.65.8816.940.81
Short-Term Investments
0.030.030.030.030.03
Cash & Cash Equivalents
2.5312.635.9116.980.84
Cash Growth
-24.79%113.83%-65.21%1921.45%-
Other Current Assets
1.020.9910.740.13
Total Current Assets
3.5513.626.917.710.97
Property, Plant & Equipment
00000.08
Goodwill and Intangibles
000.020.030.03
Other Long-Term Assets
00000
Total Long-Term Assets
000.020.030.11
Total Assets
3.5513.626.9217.751.09
Accounts Payable
1.47.842.980.410.44
Other Current Liabilities
1.241.513.440.521.45
Total Current Liabilities
2.659.356.410.931.88
Long-Term Debt
0003.910
Other Long-Term Liabilities
0.830.521.867.250
Total Long-Term Liabilities
0.830.521.8611.160
Total Liabilities
3.479.878.2712.091.88
Total Debt
0003.910
Retained Earnings
-97.1-93.47-80.25-62.19-52.4
Comprehensive Income
-0.37-0.37-0.2-0.19-0.05
Shareholders' Equity
0.083.75-1.355.66-0.8
Net Cash / Debt
2.5312.635.9113.070.84
Net Cash / Debt Growth
-24.79%113.83%-54.81%1456.36%-
Net Cash Per Share
0.131.030.792.260.18
Working Capital
0.94.270.4916.79-0.91
Book Value Per Share
0.000.30-0.180.98-0.17
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).